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Abstract 
Microbial communities inhabiting the human body, collectively called the microbiome, are 
critical modulators of immunity. This notion is underpinned by associations between changes 
in the microbiome and particular autoimmune disorders. Specifically, in rheumatoid arthritis, 
one of the most frequently occurring autoimmune disorders worldwide, changes in the oral 
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and gut microbiomes have been implicated in the loss of tolerance against self-antigens and 
in increased inflammatory events promoting the damage of joints. In the present review, we 
highlight recently gained insights in the roles of microbes in the etiology of rheumatoid 
arthritis. In addition, we address important immunomodulatory processes, including biofilm 
formation and neutrophil function, which have been implicated in host-microbe interactions 
relevant for rheumatoid arthritis. Lastly, we present recent advances in the development and 
evaluation of emerging microbiome-based therapeutic approaches. Altogether, we conclude 
that the key to uncovering the etiopathogenesis of rheumatoid arthritis will lie in the 
immunomodulatory functions of the oral and gut microbiomes. 
Introduction 
The many trillions of microbes we harbor in our bodies are not pure spectators. Indeed, they 
play a fundamental role in shaping our immune system and metabolism as has become 
increasingly evident in recent years (Cho & Blaser, 2012; Belkaid & Hand, 2014; Muszer et 
al., 2015; Lynch & Pedersen, 2016; Levy et al., 2017). These microbes, which altogether 
constitute our microbiome, are located in the gastrointestinal tract, the nose, the oral cavity, 
the skin, the vagina, and, to a lesser extent, the lungs (Cho & Blaser, 2012; Muszer et al., 
2015). Interestingly, compositional changes of the microbiome, altogether categorized as 
dysbiosis (Cho & Blaser, 2012), have been associated with a broad range of diseases 
including metabolic and autoimmune disorders (Cho & Blaser, 2012; Muszer et al., 2015; 
Levy et al., 2017). Since then, efforts have been made to define a “healthy microbiome”, but 
only as of late, with the use of sophisticated sequencing technologies and computational 
methods for data analysis, bountiful progress has been made in this field (Manor et al., 2014; 
Wang et al., 2015). One important example of this progress is the Human Microbiome 
Project (Turnbaugh et al., 2007; Human Microbiome Project Consortium, 2012; Lloyd-Price 
et al., 2017), implemented by the US National Institutes of Health. The large-scale high-
throughput analyses performed in this project yielded over 350 papers providing important 
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(Muszer et al., 2015). Dysbiotic conditions have therefore been the subject of critical studies, 
especially to uncover factors leading to this unbalance of the complex status quo in which 
microbial communities interact within and with the human body. Factors altering microbial 
homeostasis include the use of antibiotics and other drugs, changes in diet patterns, 
elimination of constitutive nematodes, the introduction of a new microbial actor, and ageing 
(Cho & Blaser, 2012; Belkaid & Hand, 2014; Lynch & Pedersen, 2016; Levy et al., 2017; 
Buford, 2017; Imhann et al., 2017; Maier et al., 2018). 
Intriguingly, despite the associations between microbiome and autoimmunity, the tissue 
targeted by autoimmune disorders is often not the same tissue where the microbiome is 
thought to exert its pathogenic role (Brusca et al., 2014; Chen et al., 2017). This is clearly 
exemplified by rheumatoid arthritis (RA), one of the most prevalent autoimmune diseases, 
affecting approximately 1% of the human population (Potempa et al., 2017). RA thus 
contributes significantly to the global morbidity and mortality and, according to the 
allegations of its increasingly higher incidence among the elderly population (Tutuncu & 
Kavanaugh, 2007; Kato et al., 2017), it is a major threat to healthy ageing (Janssen et al., 
2013; van Onna & Boonen, 2016). RA is characterized by a persistent synovial inflammation, 
which ultimately results in articular cartilage and bone damage (McInnes & Schett, 2011). 
Recent models have implicated the involvement of loss of tolerance toward citrullinated 
proteins in RA development (de Smit et al., 2011; Quirke et al., 2014; Darrah & Andrade, 
2017). Citrullination is a post-translational protein modification involving the transformation of 
a positively charged arginine residue into a neutral citrulline residue (de Smit et al., 2011). 
This reaction is catalyzed by peptidylarginine deiminase (PAD) enzymes, which are 
extremely well conserved among mammals (Gabarrini et al., 2015). Of note, human PAD 
enzymes regulate, in a variety of cells and tissues, important processes such as apoptosis, 
inflammatory immune responses, and the formation of rigid structures like skin or myelin 
sheaths (Mangat et al., 2010; Wegner et al., 2010; Witalison et al., 2015). Consistent with 










roningen user on 18 Septem
ber 2018
  
proteins gives rise to specific autoantibodies called anti-citrullinated protein antibodies 
(ACPAs) (Pischon et al., 2008; Detert et al., 2010; Quirke et al., 2014). Remarkably, ACPAs 
have a specificity of 95% and are 68% sensitive for RA (Avouac et al., 2006; Nishimura et 
al., 2007). These auto-antibodies can be detected years before the appearance of clinical 
symptoms (Arkema et al., 2013). Moreover, their serum levels strongly correlate with 
disease severity, hinting at a possible role in the progression of the disease (Koziel et al., 
2014). 
The etiology of RA is still not fully understood but, among its potential causes, certain 
genetic factors were shown to strongly correlate with the disease. Particularly, the major 
histocompatibility complex (HLA)-DRB1 locus is one of the most well-established genetic risk 
factors associated with RA and ACPAs (McInnes & Schett, 2011). Specifically, alleles coding 
for a five amino acid sequence called shared epitope, which is present in the HLA-DRB1 
region, are carried by 80% of ACPA+ RA patients (Huizinga et al., 2005) and correlate with 
disease activity and mortality (Farragher et al., 2008; Nagafuchi et al., 2016) (Fig. 1). The 
shared epitope appears to favor the binding of citrulline-containing peptides during HLA 
presentation when compared to their non-citrullinated counterparts, although this hypothesis 
seems to be applicable only to certain shared epitope alleles such as HLA-DRB1*04:01, 
*04:04 and *04:05 (Kampstra et al., 2016; Scally et al., 2017). Nevertheless, it appears that 
the genetic component is only one of the many RA-contributing factors. Specifically, 
environmental ones have always attracted great attention for multiple reasons. In particular, 
it is noteworthy that the genetic component is not sufficient to explain the recent increase in 
RA prevalence among the population (Myasoedova et al., 2010). An additional, more 
intuitive, reason is that not every individual carrying the alleles implicated in RA susceptibility 
develops RA (Holoshitz, 2013). Important clues for the identification of environmental 
triggers of RA were provided in the beginning of the 20th century, when treatment of 
periodontal infections were proven to ameliorate symptoms of patients with rheumatoid 
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health and especially the oral microbiome significantly influence the progression of RA 
(Diamanti et al., 2016; Potempa et al., 2017). Studies consistent with this line of thought 
revealed another, less apparent, actor playing a role in the pathogenesis of RA: the gut 
microbiome (Scher et al., 2016a) (Fig. 1). Indeed, Zhang et al. recently analyzed the 
microbiome composition of fecal, dental, and salivary samples of RA patients, showing that 
both the oral and gut microbiomes were dysbiotic compared to the ones of healthy 
individuals (Zhang et al., 2015). Strikingly, the dysbiotic characteristics were shown to be 
partially resolved after RA treatment, which implied an interplay between RA and the oral-gut 
axis (Zhang et al., 2015). Understanding the role of the microbiome in RA is therefore 
essential to fully understand the etiopathological landscape of RA. Additionally, this insight 
might also be useful in understanding similar, related, autoimmune diseases such as 
systemic lupus erythematosus (SLE) (de Oliveira et al., 2017). In this review, we discuss the 
most relevant findings on how the interplay of both the oral and gut microbiomes with the 
host mediate RA onset, focusing on recently proposed factors such as biofilms and 
neutrophil function. Lastly, we will address how this information could eventually lead to the 
identification of potentially druggable targets for a microbiome-based therapeutic 
management of RA and other autoimmune diseases. 
Oral microbiome, periodontitis and RA 
Oral health has been clinically associated with autoimmune diseases in a number of 
epidemiological studies (Mercado et al., 2000; Pischon et al., 2008; de Pablo et al., 2008; de 
Smit et al., 2012; Correa et al., 2017; Rusthen et al., 2017) (Tables 1 and 2). An important 
example of this is the correlation between RA and periodontitis, which is a chronic 
inflammatory disorder affecting the periodontium, the tissue supporting the teeth (Mercado et 
al., 2000). Periodontitis is a major cause of tooth-loss and one of the most widespread 
diseases in the world, with an incidence of roughly 11% in the human population (Potempa 
et al., 2017), although the disease affects between 10 to 57% of different populations 
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2008). As mentioned, a recent cause of concern for this disease is its long-known correlation 
with RA (Pischon et al., 2008; de Pablo et al., 2008). It has been reported, in fact, that 
periodontitis patients have twice the chance of contracting rheumatoid arthritis and RA 
patients are twice as likely to become edentulous (Kasser et al., 1997; Mercado et al., 2000; 
Mercado et al., 2001; Pischon et al., 2008; Dissick et al., 2010). Additionally, treatment of 
periodontitis has been shown to ameliorate symptoms of rheumatoid arthritis and vice versa 
(Ribeiro et al., 2005; Al-Katma et al., 2007; Pers et al., 2008; Ortiz et al., 2009), and the 
citrullinome of periodontopathic conditions mirrors the one of the arthritic inflamed joint 
(Konig et al., 2016). However, the molecular mechanism behind this association has not yet 
been elucidated. Nevertheless, strong evidence suggests that RA autoimmunity is triggered 
or enhanced by specific oral bacteria that are causatives of periodontal disease (Wegner et 
al., 2010; Hitchon & El-Gabalawy, 2011; de Smit et al., 2012; Maresz et al., 2013; Konig et 
al., 2016). The Gram-negative bacterium Porphyromonas gingivalis is the main suspect in 
the association between periodontitis and RA (Janssen et al., 2013). This was firstly due to 
the fact that antibody responses against P. gingivalis and specific P. gingivalis virulence 
factors appeared to correlate with RA severity and ACPA levels (Tolo & Jorkjend, 1990; 
Hitchon et al., 2010; Kharlamova et al., 2016), even more strongly than with smoking, a well-
known RA risk factor (Kharlamova et al., 2016). Secondly, in more recent times, a peculiar 
P. gingivalis enzyme has been hailed as the lynchpin of the link between periodontitis and 
RA (Rosenstein et al., 2004). This protein is the PAD enzyme of P. gingivalis (PPAD), the 
only thus far reported PAD enzyme produced by a human pathogen (Gabarrini et al., 2015; 
Gabarrini et al., 2018a; Gabarrini et al., 2018b). Antibodies against PPAD, in fact, have been 
shown to correlate with RA in several studies (Quirke et al., 2014; Shimada et al., 2016). 
Albeit contradicting observations have been made (Konig et al., 2015; Zhang et al., 2015), 
PPAD involvement in RA development was implied by experimental studies in RA murine 
models (Maresz et al., 2013; Gully et al., 2014). In these studies, either genetically 
engineered PPAD-deficient P. gingivalis mutants or the wild-type strains were used to infect 
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as higher joint damage were observed in mice infected with the wild-type strain compared to 
the ones infected with PPAD-deficient mutants, suggesting a role for PPAD in the 
exacerbation of RA. This bacterial enzyme is evolutionary unrelated to mammalian PADs, 
but it nonetheless shares with this group of eukaryotic enzymes the catalytic function (Koziel 
et al., 2014). Of note, PPAD is purported to play a role in RA etiology with two potential 
mechanisms. The first one requires the proteolytic activity of a specific class of highly 
efficient proteases secreted by P. gingivalis, named arginine-gingipains, which were shown 
to be necessary for α-enolase citrullination (Wegner et al., 2010). In vitro experiments 
showed that cleavage of host proteins by gingipains, in fact, exposes carboxyl-terminal 
arginine residues, which are the preferential targets of PPAD (McGraw et al., 1999; Wegner 
et al., 2010). This unique mode of citrullination of cleaved peptides may be the basis of the 
generation of so-called neo-epitopes at sites where PPAD activity has been suggested, such 
as the sites of infection or even distant periodontal tissues (Laugisch et al., 2016). Neo-
epitopes are epitopes to which immune tolerance has not yet been developed, consequently 
triggering an autoimmune response (Wegner et al., 2010) (Fig. 2). The second mechanism 
involves molecular mimicry (Fig. 2). It has been shown, in fact, that autoantibodies directed 
against the immunodominant epitope of human citrullinated α-enolase cross-react with P. 
gingivalis citrullinated α-enolase (Lundberg et al., 2008). These observations were further 
confirmed by Li et al., who additionally identified six P. gingivalis citrullinated peptides 
recognized by RA-derived ACPAs (Li et al., 2016). Besides the hypotheses proposing a 
causative relationship between PPAD production and RA autoimmunity, however, other oral 
microbiome-driven mechanisms mediating loss of tolerance against citrullinated proteins 
have been proposed. The first is enhanced human PAD-mediated citrullination (Maresz et 
al., 2013). Inflammatory processes that can be triggered by microbial events, in fact, have 
been known to involve PAD-mediated citrullination. In the case of chronic inflammations, 
such as periodontitis, continuous PAD activation might lead to an enhanced citrullination 
burden and, potentially, autoimmunity (Nesse et al., 2012; Valesini et al., 2015) (Fig. 2). 
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statuses and break in tolerance against citrullinated proteins (Darveau et al., 2012; Holers, 
2013). Interestingly, P. gingivalis, albeit underrepresented in the periodontal oral 
microbiome, appears to be capable of causing inflammatory responses by orchestrating oral 
dysbiosis (Hajishengallis et al., 2012; Maekawa et al., 2014). This peculiar feat, which placed 
P. gingivalis in the limelight as a “keystone pathogen”, creates a suitable environment for 
dysbiotic bacteria to persist, aggravating the loop between oral dysbiosis and inflammation 
(Hajishengallis et al., 2012) (Fig. 2).  
Besides a direct or indirect modulation of citrullination, the oral microbiome influences other 
processes, mainly involving the T cell-mediated adaptive immunity, that have been 
correlated with chronic inflammation and bone damage in the RA joints (Noack & Miossec, 
2014; de Vries et al., 2017). Specifically, T helper 17 (Th17) cells, a subset of CD4+ T cells 
normally produced against bacterial or fungal infections, have been associated with joint 
damage via mechanisms such as overproduction of the proinflammatory cytokines IL-17A, 
IL-17F, and IL-22, cross-reactivity with joint-derived antigens, or migration to the joints, 
where increased osteoclast activation mediates bone resorption (Sato et al., 2006; Hot et al., 
2011; Zhao et al., 2013; Rogier et al., 2015). These pathological Th17 cells can be produced 
in the oral cavity in response to certain periodontal pathogens (Moutsopoulos et al., 2012; de 
Aquino et al., 2014; Tsukasaki et al., 2018). Accordingly, Th17 cells and Th17-related 
cytokines are often observed in ex vivo gingival tissue samples of periodontitis patients 
(Moutsopoulos et al., 2012). Additionally, a recent study using a periodontitis mouse model 
was characterized by accumulation of, among CD4+ T cell subsets, only Th17 cells. This 
accumulation was reverted after administration of antibiotics, corroborating the hypothesized 
role of the oral microbiome in the production of Th17 cells and their ensuing responses 
(Tsukasaki et al., 2018). Accordingly, P. gingivalis was shown to specifically induce the 
production of Th17-related cytokines in vitro, a mechanism that involved gingipain 
degradation of specific cytokine mediators that favored Th17 responses (Moutsopoulos et 
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induction of periodontitis by P. gingivalis and another Gram-negative bacterium, Prevotella 
nigrescens, resulted in increased presence of Th17 cells in lymph nodes draining arthritic 
joints, and in aggravation of arthritic symptoms (de Aquino et al., 2014). The mechanisms by 
which Th17 responses are enhanced by these two oral pathogens involved IL-1 activity and 
the activation of antigen-presenting cells via Toll Like Receptor 2 (de Aquino et al., 2014). 
Additional, less explored, mechanisms underlying the interplay of P. gingivalis and RA 
etiology are further detailed in particular dedicated sections of this review.  
In recent years, studies investigating RA pathogenesis have implicated other periodontal 
pathogens aside from P. gingivalis in this disease. Schwenzer et al. demonstrated that the 
serological response against Prevotella intermedia in RA patients was associated with a 
novel ACPA directed against cCK13‐1, a newly discovered citrullinated peptide of 
cytokeratin 13, found in the periodontium (Schwenzer et al., 2017). Interestingly, unlike other 
ACPAs, this autoantibody did not correlate with a serological response against P. gingivalis, 
suggesting that ACPAs with different specificities might arise from responses to different oral 
periodontal pathogens (Schwenzer et al., 2017).  
Another study, has recently implicated the Gram-negative bacterium Aggregatibacter 
actinomycetemcomitans in the etiology of RA through the enhancement of citrullination 
(Konig et al., 2016). The mechanism behind this purported association appears to depend 
on the pore-forming leukotoxin of A. actinomycetemcomitans, LtxA. Upon a lytic stimulus 
from this toxin, destruction of the neutrophil membrane occurs, thus releasing human PADs 
and leading to hypercitrullination (Hajishengallis et al., 2012) (Fig. 2). A correlation between 
LtxA and RA was further demonstrated, as anti-LtxA antibodies were associated with ACPA 
serum titers in RA patients. The biomolecular rationale behind this mechanism is further 
explained in the “Neutrophils and RA pathogenesis” section below. 
Aside from the aforementioned studies, which have investigated the involvement of specific 
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composition in RA patients. Scher et al. 2012 analyzed the microbial composition of 
rheumatoid arthritis and control patients with and without periodontitis. New-onset RA 
patients (NORA), chronic RA (CRA) patients, and healthy control volunteers were included in 
this study, in order to pinpoint specific bacteria that are associated with different stages of 
RA progression. Among all groups analyzed, NORA patients exhibited high incidence of 
advanced periodontal disease. Intriguingly, the microbial richness and composition did not 
show a significant variation among all groups with a similar periodontitis status (Scher et al., 
2012). However, two taxa of Gram-negative bacteria were exclusively found in NORA 
patients irrespective of periodontal disease, namely Prevotella spp. and Leptotrichia spp. 
(Scher et al., 2012). Moreover, ACPA levels were positively associated with the presence 
and abundance of yet another Gram-negative bacterium, Anaeroglobus geminatus, 
indicating a possible role of this bacterium in RA initiation. An unexpected finding was that 
presence and abundance of P. gingivalis was not positively associated with RA or with 
ACPA serum titers, but only with periodontitis severity (Scher et al., 2012).  
Zhang et al. 2015, on the other hand, analyzed fecal, dental and salivary samples of RA 
patients observing a dysbiotic gut and oral microbiota compared to healthy individuals. 
Particular attention was given to Gram-negative bacterial Haemophilus species, which were 
underrepresented in the oral and gut compartments of RA patients and which negatively 
correlated with autoantibodies related to RA (Zhang et al., 2015). In contrast, the Gram-
positive Lactobacillus salivarus was overrepresented in all body sites tested of RA patients 
and positively correlated with disease activity (Zhang et al., 2015). Lopez-Oliva et al. also 
analyzed the oral microbiome composition in periodontally healthy individuals with or without 
RA. Similarly to Zhang et al., the study showed that the microbiome of RA patients is 
enriched for certain Gram-negative species with proinflammatory capacity including 
Prevotella spp. and, similarly to Scher et al., Leptotrichia spp., suggesting a possible role for 
these two bacteria in the initiation of RA (Scher et al., 2012; Lopez-Oliva et al., 2018). 
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species in the microbiome of RA patients (Lopez-Oliva et al., 2018). This is of interest 
particularly due to C. curtum‟s capability of citrullinating free arginine through the arginine 
deiminase pathway, albeit ACPAs target citrullinated proteins and not free citrulline.  
Another recent study (Mikuls et al., 2018) investigated the subgingival microbiome of RA 
patients using as control the microbiome of osteoarthritis (OA) patients, in order to pinpoint 
specific correlations with the autoimmune side of rheumatoid arthritis. Interestingly, after 
taking the periodontal status into account, no robust microbial fingerprint was found for RA 
when compared to OA (Mikuls et al., 2018). Remarkably, in contrast with previous studies, 
no correlation was observed between serum ACPA levels and abundance of bacteria that 
have been associated with RA, such as P. gingivalis, A. germinatus, Haemophilus, or 
Aggregatibacter (Mikuls et al., 2018). Additionally, an under-representation of 
Peptostreptococcus, Porphyromonas, Prevotella and Treponema species was observed in 
RA patients with periodontitis compared to OA patients with periodontitis. Of note, early RA 
patients also presented an under-representation of Prevotella and Porphyromonas species 
in the microbiome of their lung, which has recently emerged as another important extra-
articular site where RA autoimmunity may develop (Scher et al., 2016b). It must be noted 
that all the aforementioned metagenomic studies are correlational and therefore do not 
necessarily imply involvement of specific bacteria in the causation of a disease. Moreover, 
abundance of a microbe does not always correlate with the serological host response (de 
Smit et al., 2012), a factor known to have implications in ACPA formation and RA (de Smit et 
al., 2012; Li et al., 2016; Schwenzer et al., 2017). The results of these studies, however, 
albeit not giving insights into the mechanisms behind the pathogenesis of RA, might lead to 
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Oral biofilms and their role in inflammatory responses 
One of the factors leading to chronic inflammation in periodontitis is the dental biofilm, which 
consists of highly complex, organized, and dynamic microbial communities that acquire in 
this way resistance to environmental stresses, including antibiotics (Zijnge et al., 2010; 
Kostakioti et al., 2013; Sintim & Gursoy, 2016) (Fig. 3). For this reason, biofilms have been 
studied thoroughly by the medical community. However, direct correlations between biofilms 
and autoimmune disorders have not yet been examined extensively. Nevertheless, in recent 
years, studies showed the immuno-modulating properties of specific biofilm mediators 
responsible for biofilm formation. Some of such mediators are called autoinducers, the most 
conserved signaling molecules that allow “communication” among bacteria in an 
interconnecting process known as quorum sensing (Kostakioti et al., 2013). Specifically, the 
quorum sensing molecule autoinducer 2 (AI-2), which can be secreted and sensed by both 
Gram-positive and Gram-negative bacteria, has been shown to mediate the virulence and 
biofilm formation of periodontal pathogens (Kolenbrander et al., 2010). Moreover, the 
involvement of AI-2 in inflammation processes was recently demonstrated by Zargar et al., 
who analyzed the transcriptome of human intestinal epithelial cells (IECs) when exposed to 
proteins secreted by two strains of non-pathogenic Escherichia coli that differ mainly in their 
production of AI-2. The differential inflammatory response of the IECs prompted the authors 
to study the specific role of AI-2 by stimulating these cells with synthetic AI-2 (Zargar et al., 
2015). Their results suggest that IECs are able to alter the transcription of immune 
mediators, such as the neutrophil-recruiting interleukin 8 (IL-8), when faced with quorum 
sensing molecules. Moreover, in the case of RA and its alleged relationship with 
periodontitis, AI-2 molecules have been demonstrated to mediate oral biofilm formation 
(Sintim & Gursoy, 2016). Furthermore, AI-2 molecules were found to be expressed by 
periodontal pathogens, such as P. gingivalis (Chung et al., 2001; Fong et al., 2001), 
belonging to one of the nine taxa composing the main core of dental biofilms, termed 
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inducing secretion of IL-8 in oral epithelial cells (Yee et al., 2014). This observation is 
apparently supported by the finding that addition to oral bacteria of the “red complex”, a 
group of bacteria comprising P. gingivalis, Tannerella forsythia, and Treponema denticola, 
can increase the IL-8 production in oral epithelial cells (Belibasakis et al., 2013; Zargar et al., 
2015). Taken together, these results suggest that quorum sensing signaling molecules 
released by P. gingivalis might lead to an inflammatory response in the oral cavity, as 
schematically represented in Figure 2. As biofilms have been proven to represent 
inflammation-causing etiological factors of periodontitis, studies delving deeper into this topic 
might also help widening our understanding of the periodontal field and potentially 
inflammation-driven autoimmunity.  
Neutrophils and RA pathogenesis 
Another suggested oral microbiome-mediated mechanism potentially contributing to 
autoimmunity involves neutrophils. Neutrophils act as a first line of defense in periodontal 
diseases and are important regulators of both innate and adaptive immunity. Aberrant 
neutrophil functions have recently emerged as actors in the initiation and pathogenesis of 
autoimmune diseases, such as SLE and RA (Nemeth & Mocsai, 2012; Wright et al., 2014). 
In SLE, neutrophils exhibit impaired phagocytosis, have a tendency to form aggregates, 
display an elevated apoptotic behavior and an increased activation state mediated by 
nucleosomes (Abramson et al., 1983; Wu et al., 2013). Similarly, in RA, an increased 
recruitment and activation of neutrophils in synovial fluid can be observed in the early stages 
of the disease (Kaplan, 2013). A similar neutrophil phenotype is present in periodontitis 
where it has been suggested that neutrophils are key players in the initiation and 
perpetuation of the inflammation of gingival tissue (Lakschevitz et al., 2013). Interestingly, 
one important neutrophilic mechanism, which was recently strongly correlated with 
autoimmunity in SLE and RA, is the production of neutrophil extracellular traps (NETs), a 
process also known as NETosis. The NETosis mechanism involves the release, after the 
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as histones and antimicrobial peptides, forming traps for targeted microorganisms (Wright et 
al., 2014). One essential step in NETosis is the citrullination of nuclear proteins such as 
histones (specifically H2A, H3, and H4) by the PAD4 enzyme, which is abundantly 
expressed in neutrophils (Nakashima et al., 2002) (Fig. 4). Notably, in healthy individuals, 
NETs are cleared after they have performed their extracellular killing function. The clearance 
of NETs is known to be performed by extracellular DNAse I and by macrophages, which can 
engulf and digest NETs (Hakkim et al., 2010; Farrera & Fadeel, 2013). This function might 
be fundamental, considering that release into the extracellular environment of NET 
components, such as citrullinated proteins and DNA, might create a potential new source of 
autoantigens in genetically susceptible hosts, thereby potentially contributing to autoimmune 
diseases (Khandpur et al., 2013) (Fig. 2). In fact, autoantibodies against citrullinated histone 
H4, H2A and H2B are commonly found in RA patients (Pratesi et al., 2014; Corsiero et al., 
2016). Moreover, incomplete clearance of NETs, coupled with chronic inflammation, has 
already been correlated with initiation and/or development of autoimmune responses toward 
DNA and citrullinated proteins (Hakkim et al., 2010; Radic, 2014). Additionally, aside from an 
incomplete clearance of NETs, another reported factor leading to the production of 
autoantibodies against intracellular antigens is enhanced NETosis (Khandpur et al., 2013). 
Examples of the effects of these two aberrant NETosis events may be encountered in SLE 
and RA. In SLE, incomplete clearance of NETs has been observed, potentially due to the 
presence of DNAse I inhibitors or anti-NET antibodies that prevent DNAse I to break down 
NETs (Hakkim et al., 2010). In contrast, enhanced NETosis was observed in the synovial 
fluid of RA patients (Khandpur et al., 2013). Both events are likely to result in a constant 
stimulation of the immune system leading to autoantibody production (Wright et al., 2014).  
While these findings suggest that neutrophils are essential players in the pathogenesis of 
periodontitis and RA, several studies investigated the relation of these cells to the oral 
microbiome (Uriarte et al., 2016). This was especially due to the fact that specific members 
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immune mechanisms relevant for RA (Konig et al., 2016). One of such mechanisms is the 
aforementioned hypercitrullination (Romero et al., 2013). This relates to the fact that human 
PADs require calcium cations to perform their citrullinating function (Darrah & Andrade, 
2017). Consequently, when human PADs are released into the calcium-rich extracellular 
space after a NETosis event, they will tend to exert an increased and aberrant citrullinating 
function (Romero et al., 2013; Darrah & Andrade, 2017). A particular mechanism for the 
release of PADs in the Ca2+-rich extracellular milieu is observed in a study of A. 
actinomycetemcomitans, in which the bacterial toxin LtxA was shown to cause membrane 
lysis, potentially leading to the hypercitrullination scenario observed during NETosis (Konig 
et al., 2016) (Fig. 2). P. gingivalis lipopolysaccharide, on the other hand, was shown to inhibit 
apoptosis of neutrophils (Murray & Wilton, 2003) and increase epithelial secretion of IL-8 
(Yee et al., 2014), an act that stimulates neutrophil migration towards the periodontal tissue 
and into the gingival crevice (Fig. 2). These events are of particular interest, since lifespan 
prolongation and increased migratory behavior of neutrophils can lead to an augmented and 
persistent immune response, which is the ideal condition for the onset of an autoimmune 
reaction. An additional piece of evidence for the relation between oral microbiome, 
neutrophils, and RA is given by several observations showing that neutrophils, in periodontal 
pockets, employ mainly NETosis as a defense mechanism against periodontal pathogens 
(Delbosc et al., 2011; Kaplan, 2013; White et al., 2016). Clearly, since the molecular 
background of NET formation is still largely unknown, many possible hypotheses on the 
roles of this process remain to be evaluated, especially in vivo where the interplay between 
multi-species biofilms and the host can lead to the biological outcomes observed in 
autoinflammatory diseases. 
Microbial translocation to the joints 
The oral cavity is not the only location where oral bacteria, and especially P. gingivalis, have 
been thought to exert a pathogenic activity. Translocation of oral bacteria to other body 
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al., 2016; Mougeot et al., 2017). While the mechanisms used by these bacteria, or their 
components, to reach distant locations in the body have not been completely elucidated, 
several hypotheses have been postulated. For instance, a direct entry of oral bacteria into 
the bloodstream has been proven during common dental practices, such as teeth brushing, 
flushing, and mastication (Li et al., 2000; Parahitiyawa et al., 2009). This entry mechanism 
seems to be enhanced under inflammatory conditions, such as periodontitis, due to higher 
proliferation and dilation of the periodontal vasculature. A recent study showed that oral 
bacteria could be found in the liver and spleen of mice with experimentally induced 
periodontitis. Notably, this bacterial translocation stopped after tooth removal and healing of 
gingival tissues, suggesting that periodontal bacteria can disseminate during breakdown of 
the oral barrier (Tsukasaki et al., 2018). Another proposed mechanism of bacterial 
translocation is the use of host cells as a „Trojan horse‟ (Hajishengallis, 2015). P. gingivalis, 
in fact, is known to survive intracellularly within several cell types, such as macrophages and 
dendritic cells, both of which can subsequently enter the blood stream and have the potential 
to disseminate bacteria throughout the body (Singh et al., 2011; Carrion et al., 2012). 
Microbial translocation is of interest in the context of RA, due to the fact that immune 
activation mechanisms and local inflammation could occur in response to the presence of 
oral bacteria or their components in the synovial joints (Farquharson et al., 2012; 
Chukkapalli et al., 2016) (Fig. 1). Corroborating this hypothesis, several studies have 
demonstrated the presence of P. gingivalis, P. intermedia and F. nucleatum DNA in the 
synovial fluid of RA patients with periodontitis (Martinez-Martinez et al., 2009; Temoin et al., 
2012; Totaro et al., 2013). P. gingivalis DNA has also been found in the joints of a murine 
collagen-induced arthritis model infected with “red complex” bacteria. Perhaps more 
remarkably, the presence of DNA of oral bacteria in the synovial joints was found to 
associate with arthritis exacerbation (Chukkapalli et al., 2016). Although translocation of 
viable oral bacterial cells to the joint compartment of RA patients appears to be plausible, as 
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is a more supported hypothesis to explain the presence of genetic material of P. gingivalis 
and other oral bacteria in the joints of RA patients (Martinez-Martinez et al., 2009). 
The influence of the oral microbiome on the gut in the context of RA 
Albeit infrequently, oral bacteria have been implicated in non-oral infections, among them 
intra-abdominal and intra-cranial sites, the appendix, and the lungs (van Winkelhoff & Slots, 
1999). In particular, mobilization of bacteria from the oral compartment to distant 
physiological sites may involve the gastrointestinal tract, as humans continuously swallow 
oral bacteria (Arimatsu et al., 2014; Nakajima et al., 2015; Flynn et al., 2016). This view is 
supported by the incidental detection of oral bacterial DNA in human feces samples 
(Harmsen HMJ, unpublished observations). In recent years, the impact of the oral 
microbiome on the gut microbial composition has been investigated in several disease 
scenarios. Intriguingly, oral bacteria, including P. gingivalis, A. actinomycetemcomitans, and 
Fusobacterium spp. have been implicated in several gastrointestinal diseases including 
pancreatic and colorectal cancer (CRC) (Klimesova et al., 2018). Moreover, Atarashi et al., 
showed in germ-free mice that oral bacteria are capable of colonizing the gut, causing 
chronic inflammatory reactions in predisposed hosts (Atarashi et al., 2017). In the case of P. 
gingivalis, however, Geva-Zatorsky et al. recently suggested that this bacterium is not 
capable of colonizing the gut of germ-free mice since it could not be cultured from the feces 
of these mice (Geva-Zatorsky et al., 2017). Nonetheless, there is a possibility that this 
bacterium could remain viable during its passage through the acidic environment of the 
stomach due to its strong resistance to acid (Sato et al., 2017) and therefore, under proper 
conditions, potentially establishes a foothold in the human intestine. Interestingly, oral 
administration of P. gingivalis had significant repercussions on the bacterial composition of 
the gut, specifically decreasing the proportion of Bacteroidetes and increasing the proportion 
of Firmicutes (Sato et al., 2017). This, together with the fact that P. gingivalis was found to 
lower the complexity of gut bacterial communities, suggests a role for this bacterium in 
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actinomycetemcomitans was shown to modulate the gut microbiome of mice, a process that 
was correlated with metabolic and immunological changes involved in non-alcoholic fatty 
liver disease (Komazaki et al., 2017). The implications of the above-mentioned observations 
are highly relevant, considering that shifts in the gut microbial composition have been shown 
to have a significant impact on autoimmune disorders such as RA (Wu & Wu, 2012). In a 
murine collagen-induced arthritis model, in fact, P. gingivalis administration significantly 
changed the gut microbiome, while it simultaneously increased Th17 responses and 
aggravated arthritis (Sato et al., 2017). An association between the oral and gut 
microbiomes was, instead, recently described for RA patients in one of the aforementioned 
studies (Zhang et al., 2015). These individuals presented simultaneously dysbiotic oral and 
gut microbiomes, with decreased oral levels of Haemophilus spp. and increased levels of 
Lactobacillus salivarius in the gut, both of which were partially resolved after RA treatment 
(Zhang et al., 2015). Taken together, these findings suggest that bacteria belonging to the 
oral microbiome are capable of disrupting the eubiotic state of the gut microbiome, an act 
that can lead to chronic inflammation and trigger or enhance RA (Fig. 1).  
Gut microbiome and RA 
Mucosal sites are constantly exposed to microbial challenge and are considered of great 
importance in the initiation and modulation of microbiome-induced inflammatory responses. 
Among these sites, the gut is the one that has attracted most attention in the modulation of 
the host metabolism and immunity, due to its massive colonization by microorganisms 
(Belkaid & Hand, 2014). Dysbiosis of the gut microbiome has been shown to be related to 
RA pathogenesis by several studies (Scher et al., 2016a). Recently, Dorozynska et al. 
demonstrated that a partial depletion of the natural gut microbiota due to antibiotics 
aggravated arthritis symptoms in an RA murine model (Dorozynska et al., 2014). As for the 
previously observed correlation between oral microbiome and RA, the gut microbiome is 
also linked to RA through T cell mediated immunity. In healthy individuals, a CD4+ T cell 
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inflammatory role that prevents the onset of autoimmune responses (Noack & Miossec, 
2014) (Fig. 5A). Interestingly, a recent study detected decreased levels of Tregs and 
elevated levels of Th17 cells in the peripheral blood of RA patients, hinting at a Th17/Treg 
imbalance in these patients (Wang et al., 2012). Notably, this balance can be altered by the 
gut microbiome, considering that production/reduction of either Th17 cells or Tregs can be 
orchestrated by the gut microbiota via Toll-like receptor 2 (TLR2) (Nyirenda et al., 2011). 
Indeed, Tregs expressing the transcription factor Foxp3 (also called Foxp3+ Tregs) are 
known to promote homeostasis and were found to have an increase in population size 
dictated by TLR2 sensing of the polysaccharide A (PSA) of Bacteroides fragilis, a human 
symbiont (Round & Mazmanian, 2010) (Fig. 5B). Moreover, Tregs expressing the hormone 
receptor “retinoic acid receptor-related orphan receptor γt” (RORγt) were found to play an 
important role in regulating inflammatory responses in the intestine (Ohnmacht et al., 2015; 
Sefik et al., 2015; Tanoue et al., 2016). On the other hand, gut bacteria capable of causing 
inflammatory effects can also be present. This is exemplified by segmented filamentous 
bacteria (SFB), commensal murine gut microbes that have been strongly correlated with an 
upregulated Th17 response in the small intestine (Wu et al., 2010) (Fig. 5). In humans, an 
analogous process appears to be mediated by Bifidobacterium adolescentis, as this 
bacterium was shown to be capable of inducing, alone, Th17 cell production in the small 
intestine of mice (Tan et al., 2016) (Fig. 5B). Another important example comes from the 
bacterial genus Prevotella. A relative increase of Prevotella species in the gut microbiota has 
been correlated with the reduction of the Bacteroides populations (Scher et al., 2013). 
Accordingly, Prevotella species potentially suppress the anti-inflammatory effect of 
Bacteroides species such as B. fragilis. Prevotella copri, in fact, has been linked to an 
inflammatory response via Th17 cells in the context of RA (Maeda et al., 2016). Firstly, its 
prevalence in the gut microbiome of new-onset untreated RA patients was reported to be 
significantly more abundant, when compared to healthy individuals (Scher et al., 2013). 
Secondly, P. copri has been proven to produce Pc-p27, a protein that induces reactivity of T 
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2017), in 42% of new-onset RA patients (Pianta et al., 2017) (Fig. 5B). Lastly, antibodies 
against P. copri were found to be extremely specific for rheumatoid arthritis, suggesting a 
role for this gut bacterium in the pathogenesis of RA (Pianta et al., 2017). On the other hand, 
another member of the same genus, Prevotella histicola, has been found to suppress the 
inflammation in a collagen-induced murine arthritis model (Marietta et al., 2016), suggesting 
that different Prevotella species may have different effects on the pathogenesis of RA. 
Remarkably, gut bacteria are also capable of forming biofilms, another phenomenon capable 
of altering the Th17/Tregs equilibrium. Specific biofilm components, such as amyloid fibrils 
(Taglialegna et al., 2016) and DNA, which serve as building blocks in the biofilm formation, 
have been implicated in autoimmunity via TLR recognition and subsequent Th17 activation 
(Dalpke et al., 2006; Schlafer et al., 2017). Indeed, the study of Gallo et al. demonstrated 
that a specific type of amyloid fibrils, the curli, when irreversibly associated with bacterial 
DNA, triggered the production of autoantibodies in a murine lupus model, suggesting a role 
for chronic biofilm-producing enteric infections in the pathogenesis of SLE and other 
autoimmune diseases (Gallo et al., 2015). Beside directly inducing autoantibody production, 
curli produced by enteric bacteria also activate the so-called NLRP3 inflammasome in 
murine macrophages, leading to production of inflammatory interleukin IL-1β (Rapsinski et 
al., 2015). This cytokine has been implicated in the differentiation of Th17 cells (Wang et al., 
2012; Noack & Miossec, 2014) (Fig. 5B). Additionally, another study showed that upon entry 
of the enteric pathogen Salmonella enterica in the intestines of a colitis mouse model, the 
produced curli activated TLR2 responses, contributing to Th1 and Th17 activation, thereby 
promoting gut inflammation (Nishimori et al., 2012). Nevertheless, a recent study using a 
mouse model of colitis also revealed that epithelial barrier integrity, which is essential for gut 
homeostasis, is promoted by recognition of enteric bacterial curli by TLR2 (Oppong et al., 
2015). Therefore, whether bacterial curli exert a protective or pathogenic role must depend 
on other factors, such as the phagocytic capacity of macrophages to digest and clear these 
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amyloids and their roles in the gut microbiome and the pathogenesis of autoimmune 
diseases needs to be expanded. Remarkably, however, bacteria are not exclusive when it 
comes to amyloid production. Human amyloids have been extensively studied in relation to 
several neurodegenerative diseases, such as Alzheimer‟s and Parkinson‟s disease 
(Westermark et al., 2015). Similarly to the study of Gallo et al., other studies showed that 
nucleic acid-containing amyloid fibrils from human origin were also implicated in SLE 
pathogenesis (Di Domizio et al., 2012). In this context, it is particularly noteworthy that the 
microbiome was recently purported to play a potential role in the production of amyloids by 
human epithelial cells, specifically the acute phase protein serum amyloid A (SAA), which 
was shown to modulate neutrophil migratory behaviors and to induce Th17 responses in the 
gut (Kanther et al., 2014; Sano et al., 2015). Altogether, pathogenic and commensal 
members of the gut microbiome have been shown to produce amyloid fibrils in biofilms, 
while at the same time they are capable of stimulating SAA production by human intestinal 
cells, promoting a proinflammatory state (Fig. 5B). 
Microbiome-based therapeutic management of RA 
Despite the exponentially growing number of discoveries in the field of microbiomes, limited 
applications for new therapeutic avenues in the treatment of RA have been reported. 
However, pharmaceutical companies are expressing an increased interest in how to 
manipulate the microbiome to achieve positive health changes. With the understanding of 
the exact mechanisms by which specific microbes interact with one another and with the 
human host, future therapeutic strategies could aim at delivering specific bacteria to restore 
eubiosis, or ameliorate the effects of a dysbiotic microbiome. The microorganisms capable of 
conferring beneficial aspects to the host, when administered in adequate amounts, are 
termed probiotics (Bedaiwi & Inman, 2014; de Oliveira et al., 2017). An interesting example 
of this is the aforementioned case of P. histicola. This probiotic might prove itself a potential 
therapy for RA, as it was shown to suppress arthritis in humanized mice via mucosal 
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probiotics Lactobacillus paracasei and Lactobacillus casei have garnered special attention 
since they were shown to decrease inflammatory events by selectively degrading 
proinflammatory cytokines through their protease, lactoceptin (von Schillde et al., 2012). In 
the case of RA, it was reported that oral administration of L. casei resulted in decreased Th1 
effector functions in a murine collagen-induced arthritis model (So et al., 2008). Similar 
observations were made in humans, where L. casei was given to RA patients who 
subsequently showed a significant decrease in proinflammatory cytokines, resulting in a 
lower disease score compared to untreated patients (Vaghef-Mehrabany et al., 2014). 
Another meaningful contribution to this field is the study of Vong et al., in which it was 
demonstrated that the probiotic bacterium Lactobacillus rhamnosus inhibited formation of 
pathogen-induced NETs (Vong et al., 2014). Vong et al. also demonstrated the differential 
capacity of different gut microbiome subsets to elicit neutrophil activation and NETosis (Vong 
et al., 2015). Even though beneficial characteristics have been associated with the use of 
probiotic bacteria, a full-fledged status as adjunctive therapy remains to be fully 
substantiated (Pineda Mde et al., 2011; Mohammed et al., 2017). Only few studies, in fact, 
investigated the possibility of translating the beneficial effects that probiotics have on RA 
animal models to humans (Schorpion & Kolasinski, 2017; Horta-Baas et al., 2017).  
Considering the importance of a healthy gut microbiome in relation to autoimmune diseases, 
fecal microbial transplantation (FMT) has also been considered as a potential therapy for 
RA. However, while FMT proved highly effective for certain diseases, such as infectious 
colitis (van Nood et al., 2013), it still presents several challenges, especially in not yet 
established therapeutic applications. The positive results obtained by studies investigating 
the effects of FMT in autoimmune diseases such as irritable bowel disease, however, 
suggest a potential future for this technique in the therapeutic landscape of RA (Colman & 
Rubin, 2014; Scher et al., 2016a; El-Salhy & Mazzawi, 2018). Taken together, these results 
indicate that mechanistic studies on diverse commensal bacteria will very likely lead us to 
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possibly be used as a prevention treatment for autoimmune diseases such as RA. 
Nonetheless, since the gut microbiota is greatly influenced by multiple factors, the 
identification of microbiome-based approaches that can be used universally to treat or 
prevent a disease still remains a challenge. In particular, genomic makeup and diet can 
profoundly influence the microbiome composition, making them potential obstacles when 
devising a universal probiotic therapy. This sparks the need for more personalized 
approaches (Goodrich et al., 2014; Valdes et al., 2018). On the other hand, the possibility 
that a given microorganism might not be capable of surviving its passage throughout the 
stomach acids, or of effectively colonizing a target niche that is already occupied by an 
endogenous microbial population, poses a potentially greater challenge (Mimee et al., 2016; 
Dodoo et al., 2017). To overcome these hurdles, particular chassis bacteria may have to be 
chosen after extensive research on the microbial ecology of the target niche, or be re-
engineered to better suit the therapeutic needs (Mimee et al., 2016). For example, recent 
studies in mice have shown that bacterial strains engineered to metabolize a peculiar dietary 
component are capable of engrafting themselves into the already established gut microbial 
community when administered in concomitance with the respective dietary component 
(Kearney et al., 2018; Shepherd et al., 2018). Another factor that should be accounted for 
when devising a microbiome-based therapy is the variation in host responses elicited by 
different strains of the same species. This is underscored by studies of Geva-Zatorsky et al., 
who demonstrated that certain Bacteroides species display strain-specific differential 
immunomodulatory capacities (Geva-Zatorsky et al., 2017). Considering these challenges, 
the use of small molecules mimicking the interaction between beneficial bacteria and the 
host could represent a better alternative for therapy (Garber, 2015). In this respect, an 
identified bacterial molecule of interest is the aforementioned PSA from B. fragilis, which was 
shown to induce the maturation of the host immune system and to elicit protective effects 
against colitis by promoting the production of Foxp3+ Treg cells (Mazmanian et al., 2005; 
Round & Mazmanian, 2010). Based on these findings, a PSA-based oral therapy was 
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An alternative potential microbiome-based therapy for RA targets the pathogens implicated 
in the etiology of this disease, such as P. gingivalis. For example, a recent study in mice with 
experimental arthritis showed amelioration of the symptoms of both periodontitis and 
collagen-induced arthritis upon treatment with a FimA antibody (Jeong et al., 2018). This 
antibody, targeting the major fimbrillin protein of P. gingivalis, appeared to attenuate 
bacterial attachment and aggregation on the tested murine fibroblasts (Jeong et al., 2018). 
An additional potential avenue for therapy concerns the formation of biofilm by oral bacteria. 
New compounds capable of inhibiting quorum sensing molecules, such as AI-2, have been 
recently tested both in vivo and in vitro. Perhaps due to the novelty of this field, few studies 
have investigated the beneficial effects of quorum sensing inhibitors (Cho et al., 2016; Park 
et al., 2017). However, the potential therapeutic effect they demonstrated in periodontitis, 
which is mainly due to their capability to limit biofilm formation, shows some promise for 
eventual future applications in the treatment of RA. Nevertheless, with the important and 
very rapid advances in the “omics” field and the development of massive computational 
approaches, the translational potential of emerging therapeutic agents has become 
increasingly more evident. To support this, in the case of RA, Tieri et al. developed a multi-
omic map to estimate the outcomes of novel therapies focusing on several aspects of RA, 
including immune responses mediated by the gut microbiome, leading to potential targets for 
RA treatment (Tieri et al., 2014). Overall, as the scientific community continues to elucidate 
the complex relationships between the microbiome and human health, numerous therapeutic 
targets are being identified which, in turn, may be efficiently tested in silico to predict, to 
some extents, the outcome of future clinical trials. Hopefully, advances as summarized 
above will bring us one step closer to the discovery of a „universal‟ therapy to prevent or treat 
RA and other autoimmune diseases. 
Concluding Remarks 
Over the past decade, the field of microbiome research was exponentially expanded by 
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health and disease. Moreover, important technological approaches have advanced our 
understanding of how the microbiome and the host interact to maintain tissue homeostasis. 
Yet, major knowledge gaps still exist. For instance, the functional consequences of microbial 
biofilm formation need to be evaluated in more detail, because recent studies have provided 
evidence that biofilm-related phenomena and components influence the immune system. A 
second important area that needs to be explored more in depth concerns the microbial 
modulation of neutrophil activity, especially since neutrophils could represent a key source of 
autoantigens in RA patients. In particular, recent observations imply that the oral microbiome 
influences NETosis. However, further insight is needed to pinpoint the microbial populations 
responsible for altering neutrophil activities, potentially leading to the development of 
microbial therapies that restore neutrophil homeostasis. Luckily, novel „omics‟-based 
technologies to study the microbiome and its interactions with the host have recently been 
developed. These can now be exploited to overcome the limitations of classical biochemical 
and immunological approaches. Moreover, innovative computational tools will allow us to 
predict and verify the outcomes of potential therapies. As a consequence, we will surely 
experience, in the near future, a boost of preventive and therapeutic approaches to promote, 
balance, or restore the beneficial interactions between the microbiome and the human body.   
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Figure 1. Model of the influence of oral and gut microbiomes on RA 
Dysbiosis of the oral microbiome is mediated by the keystone pathogen Porphyromonas 
gingivalis. This bacterium, through direct and indirect increase of the citrullination burden, 
may mediate ACPA production in the oral cavity. Additionally, P. gingivalis may be involved 
in gut dysbiosis due to its purported translocation to the gut. Gut dysbiosis, in turn, leads to 
the production of Th1, Th17 cells, and pro inflammatory cytokines, all of which can enter the 
blood stream and localize in lymphoid tissues. In here, they can activate autoreactive B cells, 
which produce ACPAs. ACPAs produced both in the oral cavity and in the lymphoid tissues 
can migrate to the joints and potentially contribute to RA onset. Two other related sources of 
damage in the joints are IL-17-induced osteoclastogenesis and aberrant concentration of 
citrullinated proteins. Osteoclastogenesis can be directly mediated by IL-17 produced by 
Th17 cells, which can migrate from the gut to the joints. Moreover, in case of an 
inflammatory status of the joints due to the potential translocation of P. gingivalis 
components, high levels of citrullinated peptides are produced. When these peptides are 
















Figure 2. Oral microbiome-driven mechanisms that potentially contribute to RA 
Members of the oral microbiome, such as Porphyromonas gingivalis and Aggregatibacter 
actinomycetemcomitans, are actors in the complex interplay of mechanisms leading to the 
production of ACPAs. P. gingivalis can mediate the creation of citrullinated proteins through 
secretion of gingipains and PPAD. In turn, bacterial citrullinated proteins might elicit ACPA 
formation in genetically predisposed subjects via molecular mimicry. Additionally, P. 
gingivalis can indirectly contribute to citrullination by mediating proinflammatory events. 
Indeed, through secretion of quorum sensing molecules, such as AI-2, and through 
gingipains and lipopolysaccharide, P. gingivalis is able to promote inflammation and 
dysbiosis. Dysbiosis in turn triggers inflammation, which is favorable for the persistence of 
dysbiotic bacteria, creating a positive feedback loop between the two phenomena. In this 
scenario, epithelial cells secrete the proinflammatory cytokine IL-8, which recruits and 
activates neutrophils, promoting enhanced NETosis. Consequently, intracellular citrullinated 
antigens, such as citrullinated histones, are exposed and released in the extracellular milieu. 
This release of citrullinated epitopes might be an additional driver for the rise of ACPAs in 
genetically predisposed individuals. Moreover, the human PAD enzyme PAD4 is 
simultaneously released in the extracellular environment upon the neutrophil lytic event. The 
calcium-rich conditions of the extracellular milieu might lead PAD4 to hypercitrullinate human 
proteins, thus increasing the overall citrullination burden and potentially resulting in ACPA 
formation. A. actinomycetemcomitans may also break the tolerance against citrullinated 
antigens, driving ACPA production by B cells in genetically predisposed individuals with its 
enzyme LtxA. This protein, in fact, is responsible for permeabilizing the neutrophil 



















Figure 3. Visualization of Porphyromonas gingivalis in the oral biofilm 
Fluorescent in situ hybridization (FISH) analysis of an in vivo grown oral biofilm shows 
microcolonies of P. gingivalis, stained in green, that are localized in the top layer of the 
biofilm. P. gingivalis was visualized using the FISH probe PG477FITC, and additional 
eubacteria in the biofilm (red background staining) were visualized with the FISH probe 



















Figure 4. Neutrophil recruitment in periodontitis 
PAD4 staining shows the enhanced recruitment of neutrophils in the periodontal tissue of a 


















Figure 5. Alterations of the gut microbiome composition lead to an immune imbalance 
(A) In healthy individuals, the gut microbiome is in a eubiotic state. Antigen presenting cells, 
including T cells, sense microbial components via Toll-like receptor (TLR) recognition, 
triggering production of balanced levels of proinflammatory and anti-inflammatory mediators. 
(B) Environmental, microbial and genetic factors influence the composition of the gut 
microbiome, leading to dysbiosis. Overgrowth of certain bacterial species, such as Prevotella 
copri, stimulates Th1 cell responses, and simultaneously inhibits the growth of Bacteroides 
fragilis, which is responsible for Treg stimulation through secretion of polysaccharide A 
(PSA). Moreover, bacterial curli in biofilms are sensed by TLR in macrophages, which 
respond by secreting IL1-β, a Th17-activating cytokine. In mice, segmented filamentous 
bacteria (SFB) also induce Th17 differentiation by stimulating gut epithelial cells to produce 
serum amyloid A (SAA). Proinflammatory cytokines and T helper cells can disseminate 
throughout the body via the blood stream and can, therefore, promote inflammation and 




























e to RA 
















Anti-P. gingivalis levels 
higher in patients with RA vs 
non-RA controls. 
(Tolo et al. 1990) 
Significantly elevated Anti-
RgpB antibodies in PD vs 
non-PD, RA vs non-RA and 
ACPA
+





RgpB antibodies and RA 
even more than with 
smoking. 
(Kharlamova et al. 
2016) 
Anti-P. gingivalis levels 
higher in patients with RA vs 
non-RA, and in ACPA
+
 RA vs 
ACPA
-
 RA groups. 
(Hitchon et al. 2010) 
Significant association 
between anti-PPAD 
antibodies and ACPAs. 
(Shimada et al. 
2016) 
Anti-PPAD response 
elevated in RA vs non-RA 
and PD vs non-PD groups. 
(Quirke et al. 2014) 
Anti-PPAD response does 
not correlate with ACPAs and 
disease activity in RA. Anti-
PPAD antibody levels are 













Antibodies against an 
immunodominant epitope in 
citrullinated human alpha 
enolase cross-reacted with 





















g and/or mass 
spectrometry. 
citrullinated P. gingivalis 
enolase. 
ACPAs cross-reacted with 
outer membrane antigens 
and citrullinated P. gingivalis 
enolase. 






in ex vivo 
periodontal 








Large number of Th17 and 
enhanced IL-17 production in 
PD tissues compared to 
controls. Production of Th17 
related cytokines induced by 
P. gingivalis, a mechanism 
favored by P. gingivalis 
proteases. 









Accumulation of Th17 in the 
oral mucosa and draining 
lymph nodes induced by oral 
microbiota. 






model with in 
vitro exposure 
of lymph node 
cells to both 
bacteria. 
Periodontitis induced by both 
bacteria significantly 
aggravated arthritis, which 
was characterized by 
predominant Th17 cell 
responses in draining lymph 
nodes.  Th17 induction by P. 
gingivalis and P. nigrescens 
was strongly dependent on 
the activation of antigen 
presenting cells via TLR2 
and was enhanced by the 
production of IL-1 by these 
cells. 













P. gingivalis infection 
aggravated arthritic 
symptoms in a PPAD-
mediated manner. 
Significantly higher levels of 
autoantibodies and 
citrullinated proteins 
observed in mice infected 
with PPAD-proficient P. 














Increased arthritic symptoms 
and ACPA levels observed in 
mice infected with PPAD-
proficient P. gingivalis. 














by PCR and 
FISH. 
Presence of periodontal 
bacteria in synovial joints 
correlated with arthritis 
severity. Presence of P. 
gingivalis in the perinuclear 
area of cells in joint tissues. 









and serum of 
RA patients 
with PD. 
P. gingivalis and P. 
intermedia were the species 
more often found in the 
subgingival dental plaque 
and synovial fluid of RA 













Higher levels of P. gingivalis 
DNA found in synovial 
tissues of RA patients 
compared to control. 
(Totaro et al. 2013) 
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P. gingivalis significantly 
aggravated arthritis, 
increased Th17 proportions 
and IL-17 production, and 
changed the gut microbiome 
composition. 







RA joint citrullinome mirrors 
the one in the PD oral 






























Hypercitrullination in human 
neutrophils induced by the 
pore-forming toxin LtxA of 
Aa. Neutrophil challenge with 
LtxA generated citrullinated 
RA autoantigens. Anti-LtxA 
and anti- Aa responses 















Antibody responses against 
a novel citrullinated peptide 
cCK13‐1 were elevated in 
RA patients. Anti–cCK13‐1 
and anti‐cTNC5 were 
associated with anti-P. 
intermedia responses. 

































spp.and Leptotrichia spp. in 
RA patients, compared to 
non-RA controls. 
Cryptobacterium curtum as 
a discriminant between RA 
and non-RA patients 









Lower abundance of A. 
germinatus, Haemophilus 
spp., Aggregatibacter spp., 
Porphyromonas spp., 
Prevotella spp., Treponema 
spp. in RA patients 
compared to OA controls. 







Higher abundance of 
Prevotella spp. and 
Leptotrichia spp. in new-
onset RA patients. ACPA 
correlated with A. 
germinatus. Similar 
exposure to P. gingivalis 
among groups. 
(Scher et al. 2012) 




fecal, dental and 
salivary samples 
Lower abundance of 
Haemophilus spp. and 
higher abundance of 
Lactobacillus salivarius in 
RA patients vs non-RA 
controls. 
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